Study Identifies Broader Range of Clinical Presentation for Mitochondrial Disease
geralt / Pixabay

Study Identifies Broader Range of Clinical Presentation for Mitochondrial Disease

According to a story from Wellcome Center Mitochondrial Research, a multi-center collaborative study that involved researchers from different sites around the UK has resulted in an improved understanding of the…

Continue Reading Study Identifies Broader Range of Clinical Presentation for Mitochondrial Disease

The PREFER Project is Working to Include the Patient Voice in Mitochondrial Disease Research

PREFER PREFER stands for Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle. It is a multi-stage project developed by Newcastle University's Welcome Centre for Mitochondrial Research in effort…

Continue Reading The PREFER Project is Working to Include the Patient Voice in Mitochondrial Disease Research
New Discovery Adds Greater Complexity to the Genetic Basis of Mitochondrial Disease
source: pixabay.com

New Discovery Adds Greater Complexity to the Genetic Basis of Mitochondrial Disease

According to a story from news-medical.net, a recent study has reshaped the scientific understanding of the origins of mitochondrial disease. For decades any mutation that affected the mitochondrial DNA and…

Continue Reading New Discovery Adds Greater Complexity to the Genetic Basis of Mitochondrial Disease
Kidney Disease Drug May Have Future Treating Mitochondrial Disorders
argzombies / Pixabay

Kidney Disease Drug May Have Future Treating Mitochondrial Disorders

A publication at Science Daily recently announced that findings from Children's Hospital of Philadelphia suggested that cysteamine bitartrate, already used for nephropathic cystinosis (a rare kidney disease), might potentially benefit patients…

Continue Reading Kidney Disease Drug May Have Future Treating Mitochondrial Disorders
Experimental Treatment Earns Breakthrough Therapy Designation for TK2 Deficiency, a Form of Mitochondrial Disease
argzombies / Pixabay

Experimental Treatment Earns Breakthrough Therapy Designation for TK2 Deficiency, a Form of Mitochondrial Disease

According to a story from BioSpace, the biopharmaceutical company Modis Therapeutics recently announced that the US Food and Drug Administration (FDA) has granted Breakthough Therapy designation for the company's experimental…

Continue Reading Experimental Treatment Earns Breakthrough Therapy Designation for TK2 Deficiency, a Form of Mitochondrial Disease
“She Led the Life of a Carefree Child With No Limitations” Connor Family Faces Heartbreak After Losing Child to Mitochondrial Disease
source: pixabay.com

“She Led the Life of a Carefree Child With No Limitations” Connor Family Faces Heartbreak After Losing Child to Mitochondrial Disease

According to a story from the Oxford Mail, Stuart and Kira Connor were devastated when their daughter Grace, who was only three years old, suddenly passed away because of mitochondrial…

Continue Reading “She Led the Life of a Carefree Child With No Limitations” Connor Family Faces Heartbreak After Losing Child to Mitochondrial Disease
A Clinical Trial of an Experimental Treatment for Mitochondrial Disease Has Produced Promising Results
Source: Pixabay

A Clinical Trial of an Experimental Treatment for Mitochondrial Disease Has Produced Promising Results

Two organisations, NeuroVive Pharmaceutical AB from Sweden and Yungjin Pharm Corporation based in South Korea, have announced encouraging initial results from a Phase I clinical trial of the experimental medicine…

Continue Reading A Clinical Trial of an Experimental Treatment for Mitochondrial Disease Has Produced Promising Results